Both in Pharmaceuticals
Dermata Therapeutics vs Acurx Pharmaceuticals
Over the past year DRMA returned −78.3% and ACXP returned −69.5%; their daily moves had a correlation of 0.09.
DRMA −78.3% ACXP −69.5%Growth of $1, one year, split-adjusted
| Metric | DRMA | ACXP |
|---|---|---|
| Price | $1.13 | $1.31 |
| Market cap | $5.6M | $5.6M |
| Today | +0.89% | −2.61% |
| 1 month | −15.7% | −9.4% |
| 6 months | −0.9% | −62.7% |
| Year to date | −51.3% | −47.6% |
| 1 year | −78.2% | −67.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.4M | $10.7M |
| Dividend yield | — | — |
| Volatility (60d) | 85.6% | 67.3% |
| Short % of float | 3.8% | 3.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).